Literature DB >> 9852905

Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning.

D R Meldrum1, C A Dinarello, B D Shames, J C Cleveland, B S Cain, A Banerjee, X Meng, A H Harken.   

Abstract

BACKGROUND: Tumor necrosis factor-alpha (TNF-alpha) is an autocrine contributor to myocardial dysfunction and cardiomyocyte death in ischemia-reperfusion (I/R) injury, sepsis, chronic heart failure, and cardiac allograft rejection. Cardiac resident macrophages, infiltrating leukocytes, and cardiomyocytes themselves produce TNF-alpha. Although adenosine reduces macrophage TNF-alpha production and protects myocardium against I/R, it remains unknown whether ischemic preconditioning, which is mediated by adenosine, decreases postischemic myocardial TNF-alpha production. METHODS AND
RESULTS: Isolated rat hearts were crystalloid perfused with the Langendorff method and subjected to global, normothermic I/R (20/40 minutes), with or without prior transient ischemic preconditioning (5 minutes) or adenosine pretreatment. Postischemic cardiac TNF-alpha (ELISA) and function were determined (Langendorff). I/R increased cardiac TNF-alpha and impaired myocardial function. Ischemic preconditioning or adenosine decreased myocardial TNF-alpha and improved postischemic functional recovery. Sequestration of myocardial TNF-alpha (TNF binding protein) during the I/R experiments similarly improved postischemic myocardial function.
CONCLUSIONS: This study constitutes the initial demonstration that in addition to its other beneficial effects, preconditioning decreases postischemic myocardial TNF-alpha, an autocrine contributor to postischemic myocardial dysfunction. Reduced myocardial TNF-alpha production may represent the distal effector mechanism of preconditioning.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852905

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Preconditioning for protection from ischemic injury: discriminating cause from effect from epiphenomenon.

Authors:  G B Bulkley
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes.

Authors:  T Minamino; T Yujiri; P J Papst; E D Chan; G L Johnson; N Terada
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 3.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

4.  Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-alpha-induced damage.

Authors:  Jasbir S Juggi; Lamia J Hoteit; Fawzi A Babiker; Shaji Joseph; Abu Salim Mustafa
Journal:  Exp Clin Cardiol       Date:  2011

5.  The role of 17-beta estradiol in ischemic preconditioning protection of the heart.

Authors:  Fawzi A Babiker; Lamia J Hoteit; Shaji Joseph; Abu Salim Mustafa; Jasbir S Juggi
Journal:  Exp Clin Cardiol       Date:  2012-09

6.  Remote ischemic preconditioning reduces myocardial ischemia/reperfusion injury.

Authors:  Jeremy L Herrmann
Journal:  J Surg Res       Date:  2009-06-06       Impact factor: 2.192

7.  Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia.

Authors:  John Cha; Zhiping Wang; Lihua Ao; Ning Zou; Charles A Dinarello; Anirban Banerjee; David A Fullerton; Xianzhong Meng
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

8.  Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.

Authors:  Harjot K Saini; Yan-Jun Xu; Ming Zhang; Peter P Liu; Lorrie A Kirshenbaum; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2005

9.  Mechanism of cardioprotective action of TNF-alpha in the isolated rat heart.

Authors:  Satyajeet S Rathi; Yan-Jun Xu; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

10.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.